Fate Therapeutics, Inc. (FATE)
2.435
+0.10
(+4.51%)
USD |
NASDAQ |
Aug 24, 16:00
2.435
0.00 (0.00%)
After-Hours: 20:00
Fate Therapeutics Price : 2.435 for Aug. 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | 2.46 | 2.508 | 2.32 | 2.33 | 1.697M |
| Aug 20, 2026 | 2.65 | 2.65 | 2.44 | 2.45 | 1.569M |
| Aug 19, 2026 | 2.61 | 2.70 | 2.59 | 2.65 | 1.217M |
| Aug 18, 2026 | 2.59 | 2.63 | 2.534 | 2.56 | 942752.0 |
| Aug 17, 2026 | 2.57 | 2.70 | 2.51 | 2.62 | 3.184M |
| Aug 14, 2026 | 2.58 | 2.60 | 2.48 | 2.57 | 1.995M |
| Aug 13, 2026 | 2.83 | 2.85 | 2.51 | 2.52 | 2.367M |
| Aug 12, 2026 | 2.75 | 2.805 | 2.69 | 2.72 | 1.230M |
| Aug 11, 2026 | 2.79 | 2.82 | 2.69 | 2.74 | 1.283M |
| Aug 10, 2026 | 2.85 | 2.85 | 2.74 | 2.76 | 1.950M |
| Aug 07, 2026 | 2.53 | 2.88 | 2.483 | 2.80 | 4.016M |
| Aug 06, 2026 | 2.64 | 2.64 | 2.455 | 2.49 | 2.227M |
| Aug 05, 2026 | 2.615 | 2.675 | 2.56 | 2.60 | 3.387M |
| Aug 04, 2026 | 2.53 | 2.690 | 2.412 | 2.57 | 6.441M |
| Aug 03, 2026 | 2.43 | 2.55 | 2.37 | 2.50 | 1.253M |
| Jul 31, 2026 | 2.51 | 2.555 | 2.39 | 2.45 | 1.459M |
| Jul 30, 2026 | 2.36 | 2.55 | 2.345 | 2.51 | 1.698M |
| Jul 29, 2026 | 2.33 | 2.43 | 2.26 | 2.36 | 1.076M |
| Jul 28, 2026 | 2.42 | 2.42 | 2.25 | 2.32 | 1.852M |
| Jul 27, 2026 | 2.49 | 2.52 | 2.39 | 2.43 | 564084.0 |
| Jul 24, 2026 | 2.52 | 2.545 | 2.40 | 2.41 | 1.044M |
| Jul 23, 2026 | 2.57 | 2.61 | 2.47 | 2.52 | 1.637M |
| Jul 22, 2026 | 2.80 | 2.82 | 2.57 | 2.58 | 1.499M |
| Jul 21, 2026 | 2.84 | 2.86 | 2.78 | 2.83 | 1.144M |
| Jul 20, 2026 | 2.76 | 2.89 | 2.74 | 2.795 | 1.457M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Agenus, Inc. | 7.67 |
| Amgen, Inc. | 443.84 |
| Anika Therapeutics, Inc. | 21.31 |
| BioCryst Pharmaceuticals, Inc. | 9.67 |
| Imunon, Inc. | 1.604 |
Price Related Metrics
| PS Ratio | 44.89 |
| Price to Book Value | 1.852 |
| Earnings Yield | -43.24% |
| Market Cap | 284.15M |